Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

1 Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: Patient and tumor-specific factors affect the prognosis Annals of Surgical Oncology, January 12, 2015    Clinical Article

2 Aerogenous metastases: a potential game changer in the diagnosis and management of primary lung adenocarcinoma Imaging Economics, January 20, 2015    Clinical Article

3 The use of proton therapy in the treatment of lung cancers Full Text The Cancer Journal, December 10, 2014    Free full text    Review Article

4 High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer The Lancet Oncology, December 5, 2014    Review Article

5 The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients Tumor Biology, January 7, 2015    Clinical Article

6 Maintenance chemotherapy in advanced NSCLC: A population-based assessment of eligibility Lung Cancer, January 22, 2015    Clinical Article

7 Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer Journal of Thoracic Oncology, January 8, 2015    Clinical Article

8 Stereotactic body radiotherapy and treatment at a high volume facility is associated with improved survival in patients with inoperable stage I non-small cell lung cancer Radiotherapy & Oncology, January 19, 2015    Clinical Article

9 Targeting LunX inhibits non-small-cell lung cancer growth and metastasis Cancer Research, January 29, 2015    Clinical Article

10 A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer Cancer Chemotherapy and Pharmacology, January 9, 2015    Clinical Article

11 PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non–small-cell lung cancer Journal of Thoracic Oncology, January 29, 2015    Clinical Article

12 Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group... Journal of Thoracic Oncology, January 8, 2015    Clinical Article

13 The effect of different comorbidities on survival of non-small cells lung cancer patients Lung, December 26, 2014    Clinical Article

14 Identification of novel vascular targets in lung cancer British Journal of Cancer, December 24, 2014    Clinical Article

15 Lung cancer staging: The value of PET depends on the clinical setting Full Text Journal of Thoracic Disease, January 19, 2015    Free full text    Clinical Article

16 Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: A systematic review with meta-analysis Journal of Cancer Research and Therapeutics, December 22, 2014    Evidence Based Medicine

17 Dopamine is a safe anti-angiogenic drug which can also prevent 5-fluorouracil induced neutropenia International Journal of Cancer, January 6, 2015    Clinical Article

18 Current status of targeted therapy for anaplastic lymphoma kinase in non-small cell lung cancer Chinese Journal of Lung Cancer, December 31, 2014    Review Article

19 Cost and effectiveness of video-assisted thoracoscopic surgery for clinical stage I non-small cell lung cancer: A population-based analysis Full Text Journal of Thoracic Disease, January 6, 2015    Free full text    Clinical Article

20 Lilly, Merck enter collaboration agreement to research immuno-oncology combination regimens in multiple types of cancer Full Text Merck, January 14, 2015    Free full text

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Looking for a physician job? Let us help!

Register now for our free job placement service.
A career consultant will contact you soon.
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List